‘Not for sale’: Australia defends PBS against US big pharma GPs welcome plans to make PBS-listed medicines even cheaper, but it comes as US pharma giants take aim at the scheme.
PBS co-payment freeze rolls out In 2025, the maximum patient cost for all PBS medicines will remain the same as in 2024 instead of increasing with indexation.
In Practice: RACGP seeking new dermatology Chair Nominations are open for a new Specific Interests Dermatology Chair, for RACGP Fellows or members registered with AHPRA as specialist GPs.
‘Visionary’ review suggests quicker approval of new medicines New subsidised medication approvals would be streamlined and access made easier for vulnerable populations, under a new health technology plan.
New National Sustainable Asthma Care Roadmap released Each year, Australian inhalers cause the same greenhouse impact as 350,000 cars, but experts have found a way to help both patients and the climate.
In Practice: Medicines safety resources The RACGP has a new education toolkit and on-demand recordings for GPs in their role of reducing medicine-related harm.
Only 29% of clinical guidelines offer advice on deprescribing Researchers believe clinicians should have more support, but a prominent GP says numerous barriers make this a difficult proposition.
Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.
Concerns raised over possible change to medicine advertising rules The RACGP calls for greater transparency and larger fines for breaches in a review of Medicines Australia’s code of conduct.
ADHD med shortage set to end Supplies of lisdexamfetamine dimesilate should return to normal levels by the end of April, the TGA has advised.